首页>
外文会议>Congress of the International Pig Veterinary Society
>a fifi D TRIAL TO ERADICATE ACTINOBACILLUS PLEUROPNEUMONIAE FROM SEROPOSITIVE HERDS USING DOUBLE-DOSE INJECTIONS WITH ENROFLOXACIN (BAYTRIL*) AND IN-FEED MEDICATION WITH TIAMULIN (TIAMUTIN~R)
【24h】
a fifi D TRIAL TO ERADICATE ACTINOBACILLUS PLEUROPNEUMONIAE FROM SEROPOSITIVE HERDS USING DOUBLE-DOSE INJECTIONS WITH ENROFLOXACIN (BAYTRIL*) AND IN-FEED MEDICATION WITH TIAMULIN (TIAMUTIN~R)
Actinobacillus pleuropneumoniae. (Ap) is a widespread bacterial pathogen in pigs, and may cause either an acute pleuropneumonia or a chronic, often subclinical, respiratory infection. Seroepidemiological surveys have indicated that a large amount of Norwegian pigs carry antibodies against one or more serotypes of App, and the most common serotypes seem to be 2, 6, 7, 8 and 10 (1). The majority of isolated serotypes in lung tissue from pigs with acute pleuropneumonia in Norway are Ap6 and Ap8. There are several reports from attempts to eradicate App from pig herds by medication alone or by a combination of medication and partial depopulation (2, 3, 4, 5). The level of success in the described programs, however, has been low. Enrofloxacin (Baytril~R)is known to be an effective antibiotic against App (6). The aim of this field trial was to investigate whether enrofloxacin, in combination with partial depopulation and in feed medication with tiamulin, can eliminate App from infected herds.
展开▼
